Bacillus Calmette-Guérin Plus Mitomycin Versus Bacillus Calmette-Guérin Alone for Bacillus Calmette-Guérin–naïve Non–muscle-invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301)

BCG + MM was not proved superior to BCG alone, but required 39% fewer doses of BCG and fewer treatment discontinuations. These findings support consideration of BCG + MM as a pragmatic alternative to BCG alone, which could mitigate the global shortage of BCG.

Authors

Institutions

Publication Details

Journal
European Urology
Published
2026-02-01
DOI
https://doi.org/10.1016/j.eururo.2026.01.009
Citations
2
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
78.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bacillus Calmette-Guérin Plus Mitomycin Versus Bacillus Calmette-Guérin Alone for Bacillus Calmette-Guérin–naïve Non–muscle-invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301)

Leanna Cheung, Cynthia Hawks, Shomik Sengupta, Emma K. Beardsley et al.
2 citations
European Urology
Bladder and Urothelial Cancer Treatments
78.29
article

Bacillus Calmette-Guérin Plus Mitomycin Versus Bacillus Calmette-Guérin Alone for Bacillus Calmette-Guérin–naïve Non–muscle-invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301)

Leanna Cheung, Cynthia Hawks, Shomik Sengupta, Emma K. Beardsley, Patricia Bastick, Gavin Marx, Andrew Mitterdorfer, Ian Byard, Steve P. McCombie, Conrad Bishop, Jeremy Grummet, Ratnesh Kumar Srivastav, Joseph Ischia, Laurence E. Krieger, Alison Blatt, William Green, Alison Y. Zhang, Martin R. Stockler, Matthew Roberts, Dickon Hayne, Lewis Chan, Andrew J. Martin, Paul J. Anderson, Manish R. Patel, Andrew D. Redfern, Matthew Winter, Hayley Thomas
article en
2 citations

Abstract

BCG + MM was not proved superior to BCG alone, but required 39% fewer doses of BCG and fewer treatment discontinuations. These findings support consideration of BCG + MM as a pragmatic alternative to BCG alone, which could mitigate the global shortage of BCG.

European Urology
The University of Sydney (AU), The Royal Melbourne Hospital (AU), The University of Queensland (AU), The University of Western Australia (AU), Sydney Adventist Hospital (AU), Harry Perkins Institute of Medical Research (AU), Epworth Hospital (AU), Valley Hospital (US), Concord Repatriation General Hospital (AU), John Hunter Hospital (AU), Fiona Stanley Hospital (AU), Nepean Hospital (AU), Frankston Hospital (AU), The Alfred Hospital (AU), Westmead Hospital (AU), Cancer Australia (AU), Tweed Shire Council (AU), Eastern Health (AU), Footscray Hospital (AU), Northern Cancer Institute (AU), Redcliffe Hospital (AU), Austin Health (AU), National Health and Medical Research Council (AU), Monash University (AU)
Openalex Percentile: Top 0%
Bladder and Urothelial Cancer Treatments
78.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.